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Abstract 
A relatively high rate of emotional, behavioral and/or psychiatric disorders occurs among 
children and adolescents in the United States, and often these disorders are treated with 
various types of psychotropic medications. A review of the literature about adolescent 
medication self-management reveals limited information, especially for adolescents, with 
psychiatric disorders. Self-management appears to be the safest and most accurate 
method of managing a medication regimen, especially for psychotropic drugs. This study 
examined an intervention to increase skills for self-management of psychotropic 
medications prescribed for post traumatic stress disorder with adolescents who lived in a 
residential program for emotionally disturbed adolescents.  
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Introduction 
     Emotional, behavioral and/or psychiatric disorders occur at a relatively high rate 
among children and adolescents in the United States. According to the National Health 
Interview Survey published by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) for the years 2001 through 2003, 5% of all children and 
adolescents between the ages of 4 to 17 years had definite and severe emotional and 
behavioral problems.  Of those children, 48.8% were prescribed medication for those 
problems (http://www.oas.samhsa.gov/NSDUH/2k6NSDUH.html).  
     Some of the most common psychiatric disorders that children and adolescents are 
diagnosed with in the United States are major depressive disorder (33%) and attention 
deficit disorder (25%) (http://www.surgeongeneral.gov/topics/cmb/childreport). Harris 
(2005) reviewed admissions to a psychiatric hospital for children and adolescents ages 3 
to 13 years during a three month period and found that 25% of those children were 
diagnosed with juvenile bipolar disorder. Some of the most common medication types 
that have been prescribed to treat these disorders are: (a) antidepressants for depression 
(Thomas, Conrad, Casler & Goodman, 2006), (b) stimulants for attention deficit disorder 
(Thomas, Conrad, Casler & Goodman, 2006), and (c) divalproex sodium and/or lithium 
carbonate for bipolar disorder (Harris, 2005). 
     At least three potential problems are associated with using psychotropic medications 
to treat adolescents who have been diagnosed with psychiatric disorders. First, the 
effectiveness of the medications for treating adolescents has, until recently, been largely 
untested (with the exception of stimulants for attention deficit hyperactivity disorder). 
Second, if psychotropic medications are potentially effective in treating these disorders, 
we do not know the medication regimens needed to achieve maximum effectiveness. In 
fact, the levels of medication needed may be determined by the individualized responses 
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of patients to dosing regimens. Third, idiosyncratic responses to a medication such as 
adverse drug reactions (negative side effects) can occur and must be monitored carefully. 
For these reasons it is important that there be a dialogue between the physician and the 
adolescent with emotional and behavioral disorders. Patient self-report is an important 
part of determining whether a psychotropic medication is having a desired effect. 
Behavior needs to be measured as well, but self-reports are relied on a great deal by 
physicians. Because of this, the adolescent needs to be able to clearly state whether the 
medication is having a good or bad effect.   
     Levison (1991) asserted that adolescents do not typically talk with their health care 
provider about the effects of medications and recommended that physicians should 
include adolescents as members of the health management team as quickly as possible to 
ensure that the adolescent will take responsibility for using medication in a safe and 
effective manner. A critical factor influencing the variability of medication effectiveness 
may be the lack of self-report provided by patients about the efficacy of the medicine.  
     Krypel (2006) recommended that a curriculum should be developed for pharmacy 
students to teach them skills for obtaining information from patients about the effects of 
their medication. Krypel also proposed that the curriculum should include teaching the 
pharmacy students how to ask patients open-ended questions to obtain better patient 
reports about the effects of the medication, to listen to what patients say, and to ask 
additional questions for clarification or to obtain additional information. The author 
asserts that good listening skills are essential for gathering information about patient 
responses to medications. No data, however, were provided to support the author’s 
recommendation.    
      In conjunction with increasing the questioning and listening skills of pharmacy 
students (and, perhaps pharmacists and physicians as well), it might also be useful to 
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teach the adolescent patients how to record and report the effects of the medications that 
they are taking. An example of such an effort was a study by Meade, Creer and Mahan 
(2003). Although the study was done with renal transplant patients, it described a 
possible method of improving self-report from adolescents who were taking medications 
for psychiatric problems.  
     The purpose of the study by Meade et al.(2003) was to teach nine adolescent 
participants, ages 11 to 17 years old, to become members of their medical teams in order 
to manage their transplants more effectively. One of the skills taught to the adolescent 
patients was to communicate effectively with health care professionals. This skill was 
taught by having the participants prepare two questions for their doctor and two questions 
for their nurse about the participants’ treatment concerns. These questions were practiced 
using passive, aggressive, and assertive styles as patients assumed both the patient and 
the doctor role. Effective communication was modeled by facilitators. Then, the patients 
had the opportunity to ask the doctor and the nurse the questions. A post-study evaluation 
was filled out by the participants immediately after the final session. The evaluation 
consisted of seven multiple choice questions, nine questions using a Likert scale to rate 
various aspects of the program, and three open-ended questions to obtain their opinions 
about the program. Learning to question the doctor and the nurse about transplants and 
the medications were two components that were rated by the participants as “very 
helpful” (the highest rating possible on the accompanying Likert scale). In spite of the 
fact that the study did not obtain pretest measures of patient satisfaction and did not 
report whether the skills taught were correlated with improved health outcomes, similar 
interventions might be useful to increase the participation by adolescents in the treatment 
procedures used for psychotropic medications.  
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     The study reported by Meade et al. (2003) might also be expanded in several ways. 
Adolescents, for example, might report whether they are taking medications as 
prescribed, whether the effects of the medications are more evident at some times than 
others, what moods are affected, and what behaviors (both desirable and undesirable) 
they display that seem related to the medications. Additionally, adolescents might record 
and graph their own behaviors that seem to be related to the medications they are taking.  
     In the study by Meade et al. (2003) and in additional suggestions listed above, the 
information provided to medical personnel is based entirely on patients’ self-reports. This 
can present a serious difficulty. Currently, it is not possible to determine the accuracy of 
most types of self-report. For example, patient reports of mood changes and how the drug 
seems to affect the patient cannot be verified by anyone else. In some cases, however, a 
patient’s self-report of whether or not he/she took the medication at a certain time and at 
a certain dose, potentially, can be verified by observations of other people. Although 
many measures of the effects of medication are based solely on self-reports, these self-
reports appear to be the only practical method available until we can conduct studies with 
appropriate double-blind and placebo controls that evaluate whether certain drugs at 
certain dose levels seem to produce consistent verbal reports within each patient. In spite 
of the questionable status of patient self-report, the use of these reports seems to be an 
advance over not obtaining any information from the patients. These issues and other 
issues have been part of a larger field of inquiry that has examined self-management 
skills for chronic disease to improve health outcomes.  
Self-management Training to Improve Health Outcomes for Adolescents  
     DeMonaco and von Hippel (2007) suggested that a definition of self-management 
includes: (a) engaging in activities that protect and promote health; (b) monitoring and 
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managing symptoms and signs of illness; (c) managing the impacts of illness on daily 
routines; and, (d) adhering to treatment regimens.  
     Two major reviews examined  interventions to improve adolescent management of 
psychiatric disorders. Ong and Caron (2008) systematically reviewed the literature on the 
efficacy of interventions using education and training for the family and the adolescent 
who had been diagnosed with mood disorders. The authors concluded that the purposes 
of the interventions that were reviewed were to help the adolescent and his/her family 
make informed treatment decisions and to cope with the illness and its complications. 
The authors found eight studies relevant to these issues. In these studies, investigators 
used workshop formats to teach information about mood disorders, to discuss that 
information, and, in some cases, to train the participants in specific skills related to mood 
disorders. The authors observed that the lack of randomized control trials made it difficult 
to draw conclusions about the effectiveness of the interventions reviewed. In addition, the 
models used in each intervention differed greatly so comparisons were not possible.   
     Feeny, Foa, Treadwell and March (2004) reviewed another body of literature that 
addressed the treatment of post traumatic stress disorder in adolescents. Some of the 
studies reported improved symptom management using techniques that were taught to the 
adolescent to manage those symptoms. Those techniques for symptom self-management 
included muscle relaxation, diaphragmatic breathing, and problem solving techniques to 
control anger. At the same time, the authors suggested that the results from these studies 
needed to be viewed with caution because there had been no use of control groups, there 
were no comparisons within the studies to other types of interventions, and there were no 
clear empirical data on the effects of these interventions on health outcomes.  
     Thus, the available research on the interventions to improve the self-management of 
psychotropic medications for adolescents is very limited, and, as a result, this current 
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literature search was expanded to include self-management interventions for adolescents 
with other forms of chronic disease.   
     Four published reviews have summarized a great deal of the information available 
about self-management for adolescents with chronic diseases other than a mental health 
diagnosis (Goodall & Halford, 1991; Costello, Wong & Nunn, 2004;; Wysocki, 2006; 
and Kahanna, Drotar & Frazier, 2008). These review articles suggest a number of 
possible interventions to improve self-management of chronic illness. Goodall and 
Halford (1991) found that interventions that were reviewed provided information to the 
parent and child. Costello, Wong and Nunn (2004) reported attempts to: train pharmacists 
about specific child medication regimens, use pharmacist consultations with the patient 
about specific medications that were prescribed for the patient, and train children how to 
use asthma medication. Wysocki (2006) reported the use of interventions to teach parent-
child communication skills, problem solving skills and communication about diabetes 
skills. Kahanna, Drotar and Frazier (2008) reviewed interventions to develop individual 
self-management plans, educate the caregiver and the child, learn problem-solving 
techniques and social skills, develop social supports, and learn to use technology based 
interventions.   
     At the same time, those same authors noted that the following recommendations 
should be addressed in future studies: (a) more studies are needed to demonstrate that 
measurable improvements in self-management are correlated with empirical data 
showing improved health outcomes, and that more precise measurement of this 
relationship should be attempted (Goodall & Halford, 1991); (b) studies need to examine 
the long-term effects of self-management on health outcomes (Costello et al., 2004); (c) 
critical elements of some of the modestly successful interventions were not clearly 
described, and as a result, would be difficult to replicate (Wysocki, 2006); (d) studies 
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lacked uniformity of design and measurement, did not report information about 
participant health outcomes as a result of interventions, and neglected to report measures 
of fidelity to the interventions (Kahanna at al., 2008); and, (e) fewer than 25% of the 
studies reviewed provided any follow-up data (Wysocki, 2006).   
     Four published studies were not included in the review papers cited above, but did 
address the relationship between self-management and health outcomes for adolescents 
with a chronic disease (Amari, Grace & Fisher, 1995; Bruzzese, Unikel, Gallagher, 
Evans, & Colland, 2008; Buckingham, Beck, Xing, & Kollman, 2007; Wysocki et al., 
2006). The first study by Amari, Grace and Fisher (1995) attempted to reduce seizures of 
a 15-year old female with intractable epilepsy by teaching her to maintain a diet that 
would contribute to seizure reduction. A stimulus-choice procedure was used to assess 
the adolescent’s preferences for 33 foods that were part of a strict diet implemented to 
reduce the number of seizures. The adolescent was given a high preference food to eat 
after she ate a low preference food (both foods were from the recommended diet). 
Observations of the food intake and weighing of the plate after eating were used to 
measure amount of food consumption. The procedure was successful in increasing 
compliance to the diet from 60% at baseline to 97% after the intervention, and resulted in 
a 40% reduction in seizures, which was, according to the authors, an important health 
outcome.     
     Wysocki et al. (2006) taught adolescent participants self-management skills for 
chronic disease and evaluated the effects of self-management training on health 
outcomes. The authors randomly assigned 104 adolescents with Type I diabetes to a 
control group or to one of two intervention groups. The measure of self-management was 
a self-report survey and the primary health outcome was glycemic control that was 
monitored using a standard measure (HbA1c levels) during baseline, at six months and at 
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18 months post intervention. The control group received standard care which consisted 
of: (a) a meeting with a physician three or more times a year to review glucose levels; (b) 
daily injections of mixed intermediate and short-acting insulin; (c) diabetes self-
management training; (d) dietary and exercise instruction; and, (e) annual evaluations for 
long-term diabetic complications. The second group of participants received the 
Behavioral Family Systems treatment intervention that consisted of standard care plus 12 
sessions during which the family and the adolescent were trained in problem-solving, 
communication skills, and behavioral contracting techniques related to diabetes self-
management. The third group was called the “education and support group”, and received 
all of the standard care as well as 12, 45-minute presentations from a manual by the 
American Diabetes Association. The study intervention lasted for six months. 
     The difference between the average scores on the self-report measure fo self-
management taken at baseline and at 6 months (immediately post-intervention) indicated 
a higher and statistically significant difference (p=.03) for the Behavioral Family Systems 
group for a subset of participants who had a baseline measure of glycemic control greater 
than 9 (considered to be poor control). But, all three groups improved the health outcome 
of glycemic control for participants whose glucose levels were greater than 9. Training 
parents and adolescents in problem-solving, communication skills, and behavioral 
contracting techniques was related to better health outcomes as measured by improved 
glycemic control for adolescents with previously poor glycemic control (baseline of 
HbA1c greater than 9). 
     Bruzzese, Unikel, Gallagher, Evans, and Colland (2008) tested the effects of a school-
based intervention for 25 adolescents with asthma. Each participant had an asthma 
diagnosis from a medical provider, used asthma medication or had a prescription for the 
medication, and had exhibited asthma symptoms (based on self-report) an average of 
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three times per month over the last 12 months. Participants and their caregivers were 
randomly assigned to either an intervention or control group. Participants in the control 
group received no additional services from the experimenters. Participants in the 
intervention group attended six, weekly 75-minute sessions during which information and 
training were presented about asthma and asthma medication, prevention and 
management of asthma symptoms, problem-solving and coping with asthma, and 
communication skills about asthma treatment. Caregivers of participants attended five 
90-minute sessions that addressed general parenting strategies for children with asthma 
and asthma management.  
     The participant and his or her caregiver jointly rated the participant on a measure of 
asthma self-management and a measure of asthma-related health outcomes. These two 
reports were taken before the intervention, at study completion and 2 months after the 
intervention. The first report was of the number of steps the patient completed to prevent 
symptoms (of 18 possible steps), and the second report was of the number of nights the 
patient was awakened by asthma symptoms during the prior two-week period.  
     The intervention group reported taking 1.5 additional steps (baseline 8.1 and post 
intervention 9.6 steps) to prevent asthma symptoms. The control group reported taking .8 
fewer steps (baseline 7.7 and post intervention 6.9 steps). The difference was small but 
statistically significant between the two groups (p<.05). Two months after study 
completion, the intervention group reported an average 67% reduction in the number of 
nights awakened by asthma symptoms during the prior two week period compared to the 
control group’s average increase of 19% (p<.01). The authors concluded that training in 
information about asthma and asthma medications, management and problem solving 
skills related to asthma, and communication skills for asthma self-management 
contributed to improved health outcomes for the participants.  
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     Buckingham, Beck, Xing, and Kollman (2007) studied the effect of the use of the 
Continuous Glucose Monitoring System (Navigator) for prompting medication self-
management for adolescents and children. This is a device inserted under the skin to 
monitor a person’s glucose level every 60 seconds. The device sounds a beeping noise if 
glucose levels are out of the acceptable range and presumably, prompts participants to 
take additional insulin. Thirty participants between the ages of 4 and 17 years used the 
Navigator for 13 weeks. Phone calls to the participants and their caregivers occurred half 
way through the first week and at 2, 4 and 8 weeks to review data on glucose levels and 
Navigator use. Glucose levels recorded during office visit at weeks 3, 7, and 13 decreased 
from an average of 7.1% at baseline to 6.8% at the end of 13 weeks (p=.02). The authors 
asserted that the reductions in glucose levels were due to better self-management for 
timing the dose and measuring the dosage needed as a result of using the Navigator. 
     The studies cited above provide modest evidence that teaching self-management 
procedures can positively affect health outcomes. Only two of the studies, however, 
(Wysocki et al., 2006; Bruzzese et al., 2008) used an adequate experimental design to 
evaluate the effects of the intervention. And, only one of the studies (Wysocki et al., 
2006) provided data on long-term outcomes. Perhaps, the most important issue, however, 
is that these studies included attempts, however modest, to measure improvements in 
participant self-management of health care routines together with measures of health 
outcomes. Similarly, the use of interventions that teach self-management skills might 
well provide more effective ways of addressing problems with psychotropic medications 
prescribed for adolescents and possibly contribute to improved health outcomes.  
Methodological Recommendations 
     The first methodological issue that needs to be addressed in evaluating whether 
developing self-management skills affects the health outcomes of adolescents who are 
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prescribed psychotropic medications for psychiatric problems is defining what 
medication compliance is.   
     Definitions of medication compliance can be problematic. A definition provided by 
Haynes, McKibbon and Kanani (1996) was that compliance was the extent to which a 
patient’s behavior coincided with medical advice. Osterberg and Blaschke (2005) defined 
medication compliance as the extent to which a patient correctly takes medication as 
prescribed by his/her health care provider. Roberts et al. (2004) proposed that medication 
compliance be defined as taking medication in the right dosage, at the time that the 
medication was scheduled to be taken and at the correct rate over time by the person for 
whom the medication was prescribed. Murphy et al. (2005) and Bernstein et al. (2000) 
defined medication compliance as how frequently the drug was taken over a period of 
time compared to the frequency that the patient was supposed to take the drug. 
     Thus, in all of the definitions, the prescription essentially defines what the elements of 
compliance are although some definitions are more stringent than others. The most 
stringent definitions include taking the medication (a) as frequently as prescribed over 
some period of time, (b) in the prescribed amount, and (c) at the times the prescription 
indicated that the medication should be taken. 
     Even the most stringent definition of medication compliance, however, does not 
provide clear guidance as to what amounts of compliance are necessary to achieve 
positive treatment outcomes. For example, in one study, the definition of medication 
compliance was taking the medication 75% of the time as prescribed (DelBello et al. 
(2007). In another study, medication compliance was defined as taking the medication 
100% of the time as prescribed (Mears, Charlebois & Holl, 2006). Thus, although the 
prescriptions and the various definitions of medication compliance provide a basis for 
 19
measuring compliance, the definitions still leave open questions about the amount of 
compliance required to be considered adequate compliance for positive health outcomes.  
    Ideally, an adequate definition of medication compliance would be based on solid 
empirical information as to what amounts and at what times a medication should be taken 
to produce positive health outcomes. Unfortunately, the necessary empirical information 
has not been published, especially for psychotropic medications for adolescents. 
Additionally, an optimal definition of compliance may need to be determined 
individually for each patient. Currently, actual drug prescriptions typically are the best 
available estimates of what will be effective. Systematic follow-up with the patients may 
then allow prescriptions to be modified based on laboratory tests and patient reports of 
the effects of the medication.      
     A second methodological issue is that the experimental designs that have been used in 
studies of self-management have been problematic. In some studies, for example, authors 
simply recorded baseline measures of the dependent variable and then reported any 
changes in measures of those variables after the interventions were put into place (e.g. 
Bruzzese et al. 2008). Studies that have included rigorous experimental designs most 
commonly used group designs, where, for example, participants have been assigned 
(sometimes randomly and sometimes not) to one or more experimental groups or to a 
control group. These types of designs are useful in evaluating the extent to which one or 
more variables can affect the group averages, but they have been limited in their ability to 
provide the kind of evidence needed to discover procedures that are likely to be highly 
effective. This is apparent in the existing literature. 
     In developing procedures that are more likely to be effective, it seems that there are 
substantial benefits to using single subject designs in the initial stages of “discovery”. 
There are several reasons for this. First, single subject designs, such as reversal designs, 
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are less costly and cumbersome than group designs thus permitting more efficient 
evaluations of many more variables, singly and in combination, than group designs.     
     A focus on single subject designs is to reduce variability, a seemingly constant 
characteristic of medication self-management. Single subject designs may be a better tool 
for reducing variability because interventions are often used to reduce individual 
variability, whereas, group designs treat variability as an inherent characteristic of 
behavior. This is a very serious issue for the self-management of psychotropic 
medications not only because the self-management behavior that is necessary is highly 
variable and may be controlled by a number of different variables, but also because the 
effects of the medications themselves, especially medication for psychiatric problems, 
appear to have widely different effects across people and sometimes different effects 
within people at different times. A functional assessment could be done with each 
individual to determine problematic behaviors and responses to the medication. Thus, 
experimental designs that permit economical exploration of the effects of a variety 
environmental conditions as well as the variety of effects of the medications would seem 
to have an advantage as a “discovery” strategy. Promising procedures that are 
“discovered” using single-subject designs may then be evaluated to determine their 
“average” or “actuarial” effects within suitable group designs across different populations 
of people. 
     A third methodological issue is the lack of replications of interventions to improve 
medication self-management. A demonstration of the functional relationships between 
interventions and changes in self-management behaviors is critical. Most published 
studies on adolescent self-management, however, do not contain the information that is 
needed to replicate studies. In general, what seems to be needed for replication are clearer 
definitions of what constitutes self-management for psychotropic medications, well 
 21
specified and complete descriptions of intervention procedures, and the inclusion of 
fidelity measures that insure that the procedures were implemented as described. 
Enhancing Adolescent Self-management of Psychotropic Medications 
    The existing literature on improving adolescent self-management of medication for a 
chronic illness has not provided clear examples of strong and effective methodologies for 
producing self-management skills or for better health outcomes. The use of more accurate 
and reliable measures, rigorous experimental designs and more replicable procedures 
may lead to some improvement.  This alone, however, is not likely to be enough. More 
effective interventions are needed. Some suggestions for more effective interventions 
may be found in the descriptive literature about environmental conditions that are 
associated with high and low levels of self-management of medication.    
     The variables that have been associated with higher levels of effective self-
management of medication and that seem to be definable and modifiable include: (a) the 
degree to which prompting and monitoring is provided by natural supports such as 
parents (Modi, 2008; Leslie et al. 2003) and school personnel (Rogers & Bullman, 1995); 
(b) the amount of positive social consequences that can be provided (Hovell et al., 2003 ); 
and, (c) the degree of “fit” between the self-management regimen and the adolescent’s 
daily routine (Bender, 2002). The variables that have been associated with low levels of 
successful self-management of medication that also seem to be both definable and 
modifiable include: (a) negative side effects of medications such as rapid weight gain; (b) 
a denial of the diagnosis (Asadi-Pooya, 2005); and, (c) the cost of the medication 
(Jenkins, 1977). 
     Thus, interventions to improve adolescent self-management of medication might 
include prompts and reminders from parents or siblings to take prescribed medications as 
well as positive social consequences for taking medication appropriately. Careful 
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planning and inclusion of the adolescent in the planning process for the self-management 
routine might increase the probability that the medication regimen fits well with the 
adolescent’s daily life. Finally, the development of systematic ways for adolescents to 
provide input about the positive and negative effects of medications and other problems 
associated with the medication might lead to greater efforts to minimize the negative side 
effects of medications by changing dosing levels or by trying alternative solutions.     
     The teaching of medication self-management skills to adolescents with a psychiatric 
diagnosis is important for two reasons. First, adolescents are often at the point in their 
lives where they are becoming more independent and are taking greater control over 
some aspects of their daily lives. This increased independence includes the responsibility 
of taking their own medications and developing their own patterns of behavior that either 
promote or do not promote healthy lives as they become adults. Patterns of behavior that 
are developed relatively early in life often persist into later life. Thus, the establishment 
of health-promoting patterns of behavior in adolescents may help increase the number of 
health promoting behaviors that are sustained throughout an individual’s life.  
     Second, there is evidence to indicate that adolescent medication management is lower 
than for that of children who presumably rely more on their parents or other caregivers to 
support and prompt medication management. The literature about procedures to improve 
self-management for chronic disease and other medical problems also contains 
information about variables that may be useful in enhancing self-management of 
psychotropic medications for adolescents. The principles of learning also provide a 
structure to develop procedures that have been shown to be somewhat effective 
including: (a) training in problem-solving and communication skills and behavioral 
contracting techniques (Wysocki et al., 2006); (b) training about asthma and asthma 
medications, prevention and management of asthma symptoms, training in problem-
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solving and communication skills specific to asthma treatment, and relaxation exercises 
(Bruzzese et al., 2008); (c) using a stimulus choice procedure to assess preferences to be 
used as reinforcers for low preference behavior (Amari et al., 1995); and, (d) improving 
monitoring for timing the dose and measuring the dosage needed by using a monitoring 
device (Buckingham et al., 2007).   
Problems with Psychotropic Medications for Adolescents 
     If psychotropic medications are to be effective in treating psychiatric disorders then 
more reliable methods are needed to produce safe and effective regimens. The few 
studies, however, that have examined the effects of psychotropic medications report 
lower efficacy in children and adolescents than in adults (Ingersoll, Bauer & Burns, 
2004). Efficacy or the extent to which psychotropic medications really address the 
problems for which the medications are prescribed for adolescents is not well established 
in the literature. Currently, there are a large number of factors that may cause variability 
in the effects of medications prescribed for psychiatric disorders of adolescents, such as: 
(a) whether or not adolescents take medication as prescribed; (b) what the effects and side 
effects are (as well as, the intensity of those effects); (c) what dosage levels of 
medications are needed to produce beneficial effects (and to minimize undesirable side 
effects); and, (d) what the effects are of different drugs being simultaneously prescribed. 
The ability to determine the extent to which adolescent psychiatric disorders respond to 
medication is directly related to finding ways to reduce these sources of variability.  
Purpose of the Present Study 
     The purpose of this study was to teach adolescents who were diagnosed with post 
traumatic stress disorder to use self-management skills with respect to the medications 
that were prescribed for that disorder. Treatment of post traumatic stress disorder is 
particularly challenging because the symptoms are often very problematic, such as 
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physiological reactivity to certain stimuli in the environment that are associated with a 
traumatic event (associated with periods of high respiration and heart rate), reports of 
“flashbacks” and nightmares, sleep disturbance, avoidance of stimuli that are associated 
with the event, avoidance of normal activities and routines (sometimes diagnosed as 
depression), and increased levels of aggressive behavior or hyperarousal (American 
Psychiatric Association, 2000). Additionally, different psychotropic medications have 
been used to treat adolescents exhibiting the different symptoms associated with post 
traumatic stress disorder, but no randomized, control treatment studies have reported 
successful, long-term outcomes using those medications, nor have any of those studies 
been replicated (Cohen et al., 2010).  
     In addition, adolescents do not take prescribed medications for a multitude of reasons, 
and they often avoid taking psychotropic medications in particular. Some of these reasons 
may revolve around a lack of knowledge about the likely effects of the medications and 
some may be related to the undesirable side effects of the medications once the 
adolescents try taking the medications. Additionally, adolescence is a time when young 
men and women are increasingly attempting to become more independent and take 
greater control over their lives. Often, these attempts are evidenced by refusals to follow 
adult instructions. With respect to prescribed medications, the only way adolescents may 
be able to exert control over the treatment process is to refuse to take the prescribed 
medications. If any of these factors are relevant to the lack of participation in treatment 
that health care providers experience when working with adolescents with psychiatric 
disorders, perhaps teaching the adolescents skills to exert more control over what 
medications they are prescribed and the medication regimen itself would result in 
increased participation in the treatment process. Several possible avenues may be 
explored to address how to include the adolescent in the treatment process. One 
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possibility is to have a systematic educational program for adolescents so that they are 
informed as to what medications are being considered for them, what the effects and side 
effects of these medications are, and how the negative side effects might be minimized or 
even avoided by taking different medications. Additionally, adolescents need to be taught 
how to measure or evaluate both the benefits of the prescribed medication, and the 
severity of the negative side effects, and how to present this information to health care 
providers in order to advocate successfully for maintaining current medications, stopping 
the medication, changing the dose of the medication, or changing types of medications.   
Methods 
Participants 
     The participants for this study were adolescents 13 to17 years old with a diagnosis of 
post traumatic stress disorder. All participants were patients at Crittenton Children's 
Center (CCC), a residential program for adolescents with serious emotional disturbances. 
Prior to the study and independent of the study, all participants had psychotropic 
medications prescribed to help with their problems, which was part of the standard 
intervention procedures at CCC.  
     All residents who were admitted to CCC during June of 2008 for treatment, and  met 
the diagnostic and age criteria were offered the opportunity to participate in this study. 
All adolescents who indicated an interest in participating in the study and their parents or 
guardians were provided information about the study. The first 14 adolescents who 
assented to participating in the study and whose parents or guardians provided consent 
for the adolescents’ participation were included in the study. The parent/guardian consent 
form and the participant assent form are shown in Appendix A.  
     Although a total of 14 adolescents were recruited to participate in the study, four 
adolescents did not complete the study. These four adolescents did not participate 
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because they were discharged prior to the starting date for the group to which they had 
been assigned. The demographic characteristics of the participants who completed and 
did not complete the study are shown in Table 1.   
Experimental Design 
     A multiple baseline design  was used to assess the effects of the intervention. The first 
seven participants recruited were in Group One and the second seven participants 
recruited were in Group Two. As noted previously, four participants (two in each group) 
did not complete the study. For Group One participants, weekly sessions that constituted 
the intervention started after an 8-week baseline period. Thus, for these participants, data 
were collected during 8 weeks of baseline, during the 8-week intervention, and for 8 
weeks immediately following the intervention. For Group Two participants, data 
collection started and continued through a 16-week baseline, during the 8-week 
intervention, and for 8 weeks immediately following the intervention.  
Procedures 
     The intervention was a series of eight educational class meetings (one a week) that 
were one hour and 15 minutes long. Each participant signed an attendance sheet at the 
beginning of the class. Classes included information about post traumatic stress disorder, 
medications for post traumatic stress disorder, the effects and side effects of the various 
medications discussed  how to measure and record the effects and side effects of the 
various medications discussed, what types of questions participants might ask the 
advanced practice nurse who was responsible for conducting the monthly treatment 
review, how to present information to the advanced practice nurse, how to tell the 
advanced practice nurse that the medication prescribed was working effectively or was 
not effective, and how to make requests appropriately for changes in medication. The 
completion of class activities by each participant was observed and recorded by the 
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therapist who assisted the researcher in facilitating the group. The last 15 minutes of each 
class was a “party-time” during which healthy snacks chosen by the the participants were 
served and participants were free to discuss whatever they wanted to discuss. A more 
detailed description of the curriculum is available in Appendix A. 
     As part of the usual treatment program provided at Crittenton Children’s Center 
(CCC), all participants met individually with an advanced practice nurse and the 
participant’s therapist for one-half hour, once every 4 weeks at a treatment review to 
assess the participant’s progress and to discuss whether or not to change or adjust 
medications. These treatment reviews began within the first month of admission to CCC 
and continued during baseline, the intervention, and follow-up.    
     As part of the intervention, a motivational system (a point system) was used during the 
last two treatment review sessions to reward participants for their statements during the 
last two treatment reviews to the advanced practice nurse about their satisfaction and/or 
dissatisfaction with their current medication regimen.  The researcher recorded the 
statements by participants of satisfaction or dissatisfaction with the medication regimen 
as the statements occurred during the treatment review. Immediately after the treatment 
review, the researcher told participants how many points they earned. A total of 500 
points was possible. These points could be exchanged for the participant’s choice of 
prizes that were available at the Points Canteen at CCC. A total of 500 points could 
purchase an item at the Points Canteen that would cost approximately $5 in a retail store. 
     Eight types of the participant’s statements to the advanced practice nurse earned 
points (a) stating the name of the medication prescribed, (b) stating the symptom that the 
medication addressed, (c) indicating how serious the symptom was, (d) stating the extent 
to which the medication helped or did not help the symptom, (e) stating the undesirable 
side effects of the medication, (f) stating how serious the side effects were, (g) stating the 
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good effects of the medication, and (h) stating how good the effects of the medication 
were. In order to earn the maximum of 500 points, participants had to provide all eight of 
the types of statements for each psychotropic medication that was prescribed for them. 
     Initially, medication compliance behaviors were collected on each participant 
throughout the study, but there were only five incidents of noncompliance throughout the 
entire study for all the participants. As a result, that particular variable was dropped from 
the analysis.  
Class Curriculum 
     Class One included a general overview of the course, the definition of post traumatic 
stress disorder and the symptoms and causes that were associated with it. The Personal 
Medication Survey was passed out. Participants were told that they would use their 
Personal Medication Survey to present information to the advanced practice nurse during 
the two treatment reviews that followed the last class instruction. Participants were also 
told that they would be given the Personal Medication Survey that they filled out during 
the seventh class, that they would take the Personal Medication Survey with them to the 
treatment review, and they would use this survey to provide information to the advanced 
practice nurse, either by reading the information on the Personal Medication Survey or by 
using what was written on the Personal Medication Survey as a prompt. Participants were 
also told that they could earn points that could be exchanged for items at the Points 
Canteen. Then each of the participants filled out their Personal Medication Survey. This 
survey served as the pretest measure of the participants’ ability to provide the information 
asked for in the survey. A copy of the Personal Medication Survey is provided in 
Appendix B.  After the participants completed the Personal Medication Survey, the 
researcher read the assent form to the participants to ensure that they were still willing to 
participate in the study (see Appendix C).      
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      Class Two began with a knowledge pre-test (see Appendix D for the test questions) 
about how post traumatic stress disorder was diagnosed, treated, and what medications 
might have been prescribed for the diagnosis. Hospital and residential treatment was 
described. A lecture was given by the researcher about how post traumatic stress disorder 
was diagnosed, treated, and what medications might have been prescribed for the 
diagnosis. Hospital and residential treatment was described. The researcher asked if 
anyone had any questions about the lecture, or if anyone wanted to discuss some aspect 
of the lecture. When questions and the discussion about the lecture were finished, a post-
test about the diagnosis, the treatment, and the medications used to treat post traumatic 
stress disorder was administered to the participants.   
     Class Three began with the introduction to the video “Teens and Trauma” and the 
presentation of the video. At the conclusion of the video, the researcher asked the 
participants if they had any questions or opinions about the video. The researcher 
answered the questions and listened to statements about the video by the participants. 
Each participant filled out an evaluation of the video at the end of the class (see Results 
Section, Table 4 for a list of questions in the evaluation and the results).          
     Class Four began with the introduction of a video “Abused Boys, Wounded Men” and 
the presentation of the video. At the conclusion of the video, the researcher asked the 
participants if they had any questions or opinions about the video. The researcher 
answered the questions and listened to statements about the video by the participants. 
Each participant filled out an evaluation of the video at the end of the class (see Results 
Section, Table 4 for a list of questions in the evaluation and the results).          
     Class Five began with a knowledge pre-test (see Appendix D for list of questions in 
test # 2) about medications used to treat post traumatic stress disorder, what symptoms 
the medications addressed and what were the possible side effects. A pharmacist then 
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presented information about medications used to treat post traumatic stress disorder, what 
symptoms the medications addressed, and the possible side effects of the medications. An 
exercise followed during which each participant asked the pharmacist at least two 
questions about their own medication(s) and the symptom(s) that it treated, as well as at 
least two questions about the possible side effects of the medication(s). A knowledge 
post-test followed about medications used to treat post traumatic stress disorder, the 
symptoms the medications addressed, and the possible side effects.  
     Class Six began with the introduction of a guest speaker who then gave a personal 
account of the traumatic events that she experienced and how she had lived with the 
symptoms of post traumatic stress disorder. Participants were encouraged to ask 
questions and make statements to the speaker in a calm voice and without interrupting the 
speaker. At the conclusion of the speaker’s personal account, the researcher asked if there 
were any more questions or comments that the participants would like to say. When the 
participants were done with this part of the activity, the participants were encouraged to 
talk individually with the therapist who was present at the group if the participant had any 
upsetting symptoms as a result of the speaker. Each participant filled out an evaluation of 
the speaker at the end of the class (see Results Section, Table 4 for a list of questions in 
the evaluation and the results). Participants were also encouraged to talk with their 
therapist the next day about their responses to the speaker.   
     Class Seven began with a knowledge pre-test about how suicide, substance abuse and 
addiction behaviors were related to post traumatic stress disorder. The participants 
listened to a lecture about how suicide, substance abuse, and addiction behaviors were 
related to post traumatic stress disorder. Each participant then filled out the Personal 
Medication Survey. The Personal Medication Survey had places to list each participant’s 
psychotropic medications, the good effects, the symptom(s) the medication was 
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prescribed for, and the side effects of the medication, as well as to rate the efficacy of the 
medication, and the severity of the symptoms and side effects (see Appendix B for a copy 
of the Personal Medication Survey). A rehearsal of these statements followed in which 
each participant took turns reading his/her Personal Medication Survey to a partner while 
the partner listened. Then the other participant took their turn rehearsing the statements 
by reading their Personal Medication Survey. The researcher observed each rehearsal to 
determine that each participant was able to read their own survey correctly. Next, the 
group took the knowledge post-test about how suicide, substance abuse and addiction 
behaviors were related to post traumatic stress disorder.   
     Class Eight began with the researcher asking the participants to ask questions if they 
had any about the information presented over the prior seven weeks about post traumatic 
disorder. The motivational system for participants to take their Personal Medication 
Survey with them to the next treatment review and to use the survey to provide 
information to the advanced practice nurse was explained again. A game of Round Robin 
(question and answer review of knowledge) was played. Each participant took a turn 
answering a question based on the content presented in the prior six weeks of classes 
until each participant had answered four questions correctly.  Each participant filled out 
an evaluation of the curriculum at the end of the class (see Results Section, Table 4 for 
list of questions in evaluation).          
     As part of a motivational system already used at CCC, points were earned during each 
class for the following behaviors: (a) complete pre and posttest and sign in sheet, (b) 
complete group activity, (c) ask a question or make a comment about the focus of the 
group, (d) use a normal voice tone, (e) make a supportive comment, (f) speak when called 
on, (g) say please or thank you when appropriate, and (h) wait turns. Points could be 
taken away for the following behaviors: (a) using a loud voice, (b) making fun of others, 
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(c) insulting someone, (d) sitting with one’s back to the group, (e) not focusing on the 
topic, (f) calling someone names, (g) throwing things, (h) physical aggression (including 
but not limited to pretending to or actually having contact with a person while trying to 
bite, hit, or kick a person). A participant could earn up to eight points but could have 
points taken away as well. The points earned were added to the total points earned each 
week by the participants and were used determine what activities the participants could 
participate in. For example, a level four meant that the participant could go off the unit 
for field trips, etc. whereas a level one meant that the participant had to remain on the 
unit except for attending school and meals. 
     Finally, an additional motivational system was used to reward participants for 
completing each class activity. Each week at the end of class, the participants were asked 
what they would like for a healthy and inexpensive treat for the next class if they were 
successful in completing the activity during the next class. Two options were chosen so 
that allergies and preferences for all participants were considered. The two healthy snacks 
were available the next week for participants who completed the group activity.      
Measures 
     In the weekly classes, the effects of the intervention were evaluated by gathering data 
on the behavior of participants. In the monthly clinical reviews, the effects of the 
intervention were evaluated by gathering data on the behaviors of the participants and the 
advanced practice nurse.  
     In the weekly classes, two types of information about participant knowledge were 
collected. The first type of information was the Personal Medication Survey that was 
collected in the first and the seventh classes. The eight questions on that survey asked for 
a list of all of the psychotropic medications prescribed for the participant, the good 
effects of the medication, the symptom that the medication was prescribed to treat,the 
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side effects of the medication, the efficacy of the medication and the severity of the 
symptoms and side effects (see Appendix A for a complete copy). The researcher 
compared this information to the medication chart and had the participant correct any 
errors. The second set of information was three tests of participant knowledge about the 
information presented in three classes (tests are contained in Appendix D).   
     A Participant Program Evaluation Survey about the series of classes was administered 
to each participant who attended Class Eight for both groups. The survey contained six 
questions about the significance of the course and the acceptability of the procedures and 
was rated using a 5 point Likert scale from “Not at all helpful” (1) to “Very helpful” (5). 
The first question was “How helpful was this course for you?” The second question was, 
“How helpful to you were the two videos about teens with post traumatic stress 
disorder?” The third question was “How helpful was the pharmacist who came to talk to 
you about your medication?” The fourth question was “How helpful was the Daily 
Symptom Chart that you used?” The fifth question was “How important was the person 
with a mental illness who came to talk to you about his/her life?” The sixth and final 
question was “How helpful do you think this course will be to future residents?”   
     During the monthly treatment reviews, the behaviors of the participants and of the 
advanced practice nurse were recorded. The participant behaviors that were recorded in 
the monthly treatment reviews were oral statements or questions  by each participant of: 
(a) naming each of the prescribed psychotropic medications, (b) the symptoms that each 
of the medication(s) was prescribed for, (c) a rating of the severity of the symptom(s), (d) 
a rating of the effect of the medication on the symptom, (e) stating the side effects caused 
by the medication, and (f) a rating of the severity of the side effects of the medication(s), 
(g) stating the positive effects of the medication, and (h) a rating of the positive effects of 
the medication. These statements were recorded on observation sheets by the researcher 
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each time the statements occurred during treatment reviews. The statements from the 
Personal Medication Survey which: (a) rated how the medication affected the symptom, 
and (b) rated the side effects of the medication were rated as to whether the statements 
were: (a) statements of satisfaction and dissatisfaction about medications that were not 
specific to a drug, the dose, the route of drug administration, or the time of administration 
as well as statements of satisfaction or dissatisfaction that were specific to a drug, the 
dose, the route of drug administration, or the time of administration; (b) requests for a 
change that were not specific to a drug, the dose, the route of drug administration, or the 
time of administration as well as requests that were specific to a drug, the dose, the route 
of administration, or the time of administration. In addition, any statements of 
satisfaction, dissatisfaction or requests for change that were made independent of the use 
of the Personal Medication Survey or made during treatment reviews before the survey 
was introduced were recorded as well on the observation sheet and rated as preference 
statements.    
     The behaviors of the advanced practice nurse that were recorded for the monthly 
treatment reviews were responses by the advanced practice nurse to change the 
medication or not to change the medication such that  it was: (a) in agreement with 
participant preference statements about their psychotropic medication regimens or agreed 
with the participant but only after the participant agreed to the alternative response of the 
advanced practice nurse; (b) made in the absence of the participant’s preference 
statements; and, (c) disagreed with the participant’s preference statements.  
 Reliability of Recording Measures 
     Reliability of the observational data collected during treatment reviews for participant 
statements made about their medication was evaluated during  24 % of the treatment 
reviews (19 out of 80). The researcher and the advanced practice nurse independently 
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recorded whether or not a participant said one of the eight types of participant statements 
or questions that earned points listed above for each of the psychotropic medications 
prescribed for the participant. The average agreement between the researcher and the 
advanced practice nurse was 92%.  
     A second reliability evaluation was conducted for the scoring of “yes” or “no” for the 
category of was there a “change to medication regimens. An independent rater (a nurse at 
CCC) and the researcher independently reviewed 95 medication prescriptions for 
participants during the entire duration of the study. The independent rater and the 
researcher scored a “yes” if a change had been made to the participant’s prescription and 
“no” if there was no change. The raters agreed upon whether or not a change had 
occurred for 94 of the 95 instances examined (99%). A total of 44 changes in medications 
prescribed occurred during treatment reviews for the duration of the study.  
     A third reliability evaluation was conducted to determine if scoring “yes” or “no” for 
the category of “changes to medication regimens were made in response to participant 
preference statements or participant agreement to the change”. An independent rater (a 
nurse at CCC) and the researcher independently reviewed 97 medication prescriptions 
that were active during the study and scored whether or not the prescriptions were 
changed or not changed and whether the decisions were consistent with preference 
statements or agreements to change made by participants during the treatment review. 
The independent rater and the researcher scored a “yes” if a prescription change had been 
made in response to a preference statement made by the participant. A “yes” was also 
scored if the participant agreed to no change or a change to another medication if the 
participant agreed to the decision after a discussion with the advanced practice nurse. A 
total of 48 “yes” categories were rated. A “no” was scored if the change was made in the 
absence of a preference statement by a participant or if a prescription either stayed the 
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same or was changed and this decision was not consistent with a participant’s stated 
preference. A total of 49 “no” categories were rated. The raters agreed on the scoring of 
“yes” or “no” in 86 of these conditions. The raters agreed 86 times (N=97, 89%).      
Results 
     Demographics for participants for gender, age, custodial arrangements, racial 
characteristics, and diagnosis are reported in Table 1. The gender breakdown for all 
participants who completed the study was eight females and two males.  The non-
completers were four females. The average age for completers was 15 years, 8 months. 
The average age for Non-completers was 14 years, 7 months. Custodial arrangements 
were reported for each participant and 7 of the 10 participants who completed the study 
were in state custody. Three of the four participants who did not complete were in state 
custody. The racial characteristics for completers were two African Americans and eight 
Caucasians. The racial characteristics for the non-completers (n=4) were; two African 
Americans and two Caucasians. 
     All participants who participated in the study had been diagnosed with Post Traumatic 
Stress Disorder. In addition, other diagnoses were reported as well. The following 
diagnoses were recorded: (a) bipolar disorder (5), (b) attention deficit hyperactivity 
disorder and bipolar disorder (3), (c) attention deficit hyperactivity disorder (1), and (d) 
conduct disorder (1). The average number of medications prescribed for each participant 
in Group One was 2.3 medications and for Group Two was 2.07.   
     The percent of sessions attended out of the eight sessions offered was: 80% for Group 
One, 78% for Group Two, and 79% for both groups combined. (see Table 2).         
     Knowledge pre- and post-test scores are presented in Table 3. Scores for the combined 
groups for Test One indicated that the average increase in scores was 20%. Scores for the 
combined groups for Test Two indicated that the average increase in scores was 9%. 
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Scores for the combined groups for Test Three indicated that the average increase in 
scores was 8%. The scores indicated that there was not a substantial increase in scores for 
each test.   
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Table 1.  
Participant Demographics (at Time of Admission to Program) 
 Group 1   Gender      Age                    Custody     Race______    Diagnosis_____             
    1      female      14 yrs.,   9 mo.   State      Caucasian          PTSD, Bipolar Disorder 
    2      female      15 yrs., 10 mo.   State  African American PTSD, Conduct Disorder 
    3      female      16 yrs.,   0 mo.   Parent    Caucasian       PTSD, Bipolar Disorder,  
                                                                                                     ADHD 
    4           female      16 yrs.,  2 mo.    Parent     Caucasian         PTSD, Bipolar Disorder,  
                                                                                                     ADHD 
    5           male          17 yrs.,  8 mo.   State       Caucasian         PTSD, Bipolar Disorder 
*12         female       15 yrs.,  8 mo.    State   African American PTSD, Bipolar Disorder 
*14         female       14 yrs.,  3 mos.  State        Caucasian         PTSD, Conduct Disorder 
________________________________________________________________________                         
Group 2   Gender       Age                   Custody       Race______ Diagnosis_______ 
    6          female      16 yrs., 5 mo.      State          Caucasian     PTSD, Bipolar Disorder,  
                                                                                                    ADHD                                                         
    7          female      13 yrs., 10 mo.    Parent        Caucasian     PTSD, Bipolar Disorder  
    8          female      14 yrs., 4 mo.      State          Caucasian     PTSD, ADHD              
    9          female      14 yrs., 2 mo.      State          Caucasian     PTSD, Bipolar Disorder 
   10         male         17 yrs., 1 mo.      State          Caucasian     PTSD, Bipolar Disorder 
 *11         female      16 yrs., 0 mo.      State African American PTSD, Bipolar Disorder 
 *13         female      12 yrs., 10 mo.    Parent        Caucasian    PTSD, Bipolar Disorder 
________________________________________________________________________ 
*Participants who were discharged from the residential program prior to the start of the    
  intervention 
 
 
 
Table 2.  
Percent of Sessions Attended by Participants 
_______________________________________________________________________ 
Group One  Percent Attendance      Group Two       Percent Attendance                  
Participant 1                         75%                        Participant 6              63%  
Participant 2                         75%                        Participant 7              100% 
Participant 3                         75%                        Participant 8              75%   
Participant 4                         100%                      Participant 9              88% 
Participant 5                         75%                        Participant 10            63% 
_______________________________________________________________________    
Average Attendance             80%                                                          78% 
Average Total Attendance for both Groups Combined: 79% 
________________________________________________________________________ 
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Table 3.  
Pre-, Post- and Difference Scores (Percent) for Knowledge Tests by Participant, by 
Group and Combined Across all Participants  
___________________________________________________________________ 
Group One:  
Pre /Post Difference Scores       Test One             Test Two              Test Three 
                                                   Diagnosis            Medications         Suicide 
                                                   Treatments          Symptoms            Substance Abuse  
                                                   Medications        Side effects          Addiction 
___________________________________________________________________                            
Participant 1                               75/75 (0%)         80/60   (-20%)     100/100 (0%)                 
Participant 2                               75/100 (25%)     80/100 (20%)        66/66 (0%) 
Participant 3                               75/75 (0%)         100/80 (-20%)       66/66 (0%)  
Participant 4                               50/75 (25%)       80/80 (0%)             66/100 (34%) 
Participant 5                               75/100 (25%)     40/80 (40%)           100/100 (0%)   
Average  Percent Increase         70/85 (15%)        76/80 (4%)             80/86 (6%) 
__________________________________________________________________                                    
Group Two:  
Pre /Post Difference Scores       Test One             Test Two              Test Three  
Participant 6                               -----------             25/100 (75%)     80/100 (20%)                 
Participant 7                               0/50   (50%)       100/66  (-44%)     80/80   (0%) 
Participant 8                               75/75  (0%)          ----------               ----------    
Participant 9                               50/75  (25%)       100/100 (0%)       80/100 (20%) 
Participant 10______________ 75/100 (25%)       ----------               66/66   (0%)   
Average  Percent Increase         50/75 (25%)        75/89 (14%)         77/87 (10%) 
__________________________________________________________________ 
Combined Across all Participants: 
Pre /Post Difference Scores       Test One             Test Two              Test Three  
                                                   60/80 (20%)        76/85 (9%)           79/87 (8%)     
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Observed BehaviorDuring Treatment Reviews 
     The participant behaviors that were recorded in the monthly treatment reviews were 
oral statements or questions  by each participant of: (1) naming each of the prescribed 
psychotropic medication, (2) the symptom that the medication was prescribed to treat, (3) 
a rating of the severity of the symptom, (4) stating the side effect caused by the 
medication, (5) a rating of the severity of the side effect, and (6) stating the positive effect 
of the medication. Scores for each group were calculated in percentages and were 
reported for each group for each treatment review (see Figure 1). These scores indicated a 
substantial increase in the number of times that these verbal behaviors were observed 
from the first treatment review to the final treatment review for both groups.   
     The total number of preference statements recorded during the treatment reviews 
throughout the study indicates that there was a substantial increase made from the first 
treatment review to the final treatment review for Groups One and Two (see Figure 2). 
An increase in statements of satisfaction was most pronounced especially for Group Two.  
     The response of the participant to the advanced practice nurse’s decision about each 
medication during the treatment reviews changed in type and frequency for both Group 
One and Group Two from the first treatment review to the last treatment review (see 
Figure 3). The number of times that the participant agreed with the response of the 
advanced practice nurse about each medication decision increased substantially for both 
groups. The number of responses by the advanced practice nurse that did not agree with 
preference statements made by the participant changed very little from the first to the 
final treatment review. The number of responses by the advanced practice nurse in the 
absence of a participant preference statement changed very little as well.   
     A total of 14 medication changes were made for Group One during the study. A total 
of 30 medication changes were made for Group Two during the study (see Figure 4).  
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Participant Evaluation Survey   
     In Class Eight a Participant Program Evaluation Survey was given to all of the 
participants.  The survey used a 5 point Likert scale (see Table 4) and no rating fell below 
the midpoint. However, the lowest ratings occurred for the two videos (3.9) and for the 
Daily Symptom Tracking Sheet (3.8). The highest rating was for the pharmacist who 
answered questions (4.9) (see Table 4).     
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Figure 1. Participant statements to advanced practice nurse during treatment 
reviews about prescribed medications 
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Figure 2. Number of preference statements made by participants to the advanced 
practice nurse by type for each treatment review 
 
 
 
 
 
 
 
 
 
Figure 2. Number and Types of Preference Statements for Each Treatment Review  
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Figure 3. Responses of Advanced Practice Nurse to Statements by the Participants  
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Figure 4. Number of changes made by advanced practice nurse to medications 
prescribed for participants during each treatment review. 
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Table 4. 
 Participant Program Evaluation Survey 
TEEN SURVEY                                        Group One    Group Two         Combined Rating 
                                                                      (n=5)                  (n=3)                      (N=8) 
1. How helpful was this course for you?              4.0                 4.4                           4.2 
2. How helpful to you were the two videos  
     About teens with PTSD?                                 4.0                 3.8                           3.9    
3. How helpful was the pharmacist who  
came to talk to you about your medications?       5.0                 4.8                           4.9           
4. How helpful was the Daily Symptom  
Chart that you used?                                             4.0                 3.6                           3.8 
5. How important was the person with  
a mental illness who came to talk to you about  
his/her life?                                                           4.3                 4.75                         4.5 
6. How helpful do you think this course  
will be to future residents?                                   4.3                  4.6                           4.4 
 
 
 
 
Discussion 
 
     The purpose of this study was to teach participants self-management skills with 
respect to communicating with the advanced practice nurse about medications prescribed 
for the participants. Part of the self-management skills taught to participants was to 
present or discuss “factual” information with the advanced practice nurse such as what 
medications were prescribed for the participant, and what the positive effects of the 
medication were supposed to be. The majority of the information presented, however, 
was information that was available only to each participant such as what were the effects 
and side effects of the medications,  how good or bad the medications made a participant  
feel, and whether a participant wanted to continue with the present medication(s) or 
switch medication(s). It was this information that only the participants could provide that, 
presumably, should be part of the decision making process of the advanced practice 
nurse.  
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     As shown in Figure 1, during the baselines for both groups of participants, the number 
of statements the participants provided about their medication to the advanced practice 
nurse was relatively low. The number of these statements from participants in Group 1, 
however, gradually increased over the first three sets of clinical reviews. Statements from 
participants in Group 2 also increased during baseline, but only slightly. For both groups 
of participants, the number of statements made to the advanced practice nurse increased 
moderately during the two sets of clinical reviews that were held during the time when 
the class sessions were held (the intervention period labeled on the graphs).   During the 
follow-up period for both groups (just after the final class period when participants 
practiced how to present information to the advanced nurse with each other and when 
participants received points for making statements to the advanced practice nurse)  the 
number of participant statements about their medications increased substantially. 
     Thus, the overall effects of the class sessions, the practice participants had with each 
other as to how to give information to the advanced practice nurse, and the use of points 
to reward giving information to the advanced practice nurse produced a substantial 
amount of information on which the advanced practice nurse could make a more 
informed decision. Interestingly enough, the greatest increases in statements made by 
participants from baseline to the follow-up period were statements of satisfaction with 
their current medications (see Figure 2). 
     The data shown in Figure 3 indicate an increasing amount of decisions made by the 
advanced practice nurse that were in agreement with or consistent with the statements of 
preference by the participants. It could be argued that this was true only because the 
participants made more preference statements with which the nurse practitioner could 
agree.  If this were true, however, there also should be an increasing amount of decisions 
made by the advanced practice nurse that were in disagreement with the statements of 
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preference by the participants. This was not the case. The number of decisions made by 
the advanced practice nurse that were in disagreement with the statements of preference 
by the participants remained relatively stable while the decisions made by the advanced 
practice nurse that were in agreement with the statements of preference by the 
participants increased substantially over time. This was especially apparent during the 
follow-up period and, together with the increasing amounts of satisfaction statements by 
the participants, suggests a developing partnership between the advanced practice nurse 
and the participants in achieving agreed-upon outcomes of the medication(s) prescribed.   
     The present study had a number of limitations. First, the sample of participants was 
drawn from one program site and the majority of participants were female. Thus, the 
participants in this study may not represent the breadth of diversity of adolescents 
diagnosed with post traumatic stress disorder. Nevertheless, the present sample of 
participants responded to the intervention in ways that suggest the exercise of self-
management with the prescribing nurse.  A second limitation was that only one advanced 
practice nurse was involved in the study and made the decisions as to what medications 
to prescribe. Hopefully, other medical personnel who prescribe medications for disorders 
such as post traumatic stress disorder would also be responsive to medication self-
management skills of their adolescent patients. This, of course, requires additional 
replications of the procedures across an increased number of participants and prescribing 
agents. 
     A third limitation was the experimental design used in the study was not a “true” 
multiple baseline design. In a “true” multiple baseline design, interventions are 
implemented only after there is no trend in the behaviors being studied or that the trend in 
the behaviors being studied is in a direction opposite from that expected to be produced 
by the intervention. Clearly, this was not done in the present study: for both groups the 
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intervention started during a time when the behaviors of the participants that were being 
measured were increasing (substantially for Group 1 only slightly for Group 2). Thus, the 
experimental design used in this study was flawed and this flaw makes it difficult to 
conclude definitely that the intervention was responsible for the increased behaviors of 
the participants. Unfortunately, the requirements of a “true” multiple baseline design 
could not be followed because of the need to complete the study before participants were 
discharged from CCC.   
     A fourth limitation of the study was that the intervention was composed of several 
components and it is difficult to determine which of the components were responsible for 
the increases in medication self-management skills. We suspect that the practice the 
participants had with each other about how to provide statements and information to the 
advanced practice nurse and the point motivational system used during follow-up were 
particularly useful.   
     A fifth limitation was that the implementation of the intervention was not measured to 
ensure that the procedures used in this study were put into place as described. Future 
researchers might well benefit from having two or more observers measure the essential 
elements of the intervention to assess whether the class sessions and other parts of the 
intervention were conducted as described. 
     Finally, this study does not include any measures of the maintenance of the behaviors 
that were displayed by the participants. A lack of successful, long-term self-management 
can have serious implications for chronic disease. Dobbels et al. (2005), for example, 
found that the survival rates for adolescent transplant recipients were lower than for 
younger recipients when tracked and compared for five years. The authors asserted that 
the lower survival rates were associated with lower, long-term self-management of 
medication regimens for the adolescent patients studied. Because the symptoms of post 
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traumatic stress disorder can last for many years, the need for effective self-management 
of medications should be a skill that is maintained for many years. Thus, information 
about environmental supports that can maintain the self-management behaviors learned 
during this intervention will be critical for long-term success with the self-management of 
medications for adolescents with post traumatic stress disorder.                                                                   
     The participants for this study were drawn from a population seldom studied in 
research on adolescents. Several of the participants were in state custody. The need for 
this population to be successful in managing their own medication becomes apparent 
when viewed in light of the number of changes in foster care placements that can occur 
for this population. The need to train adolescents in foster care about how to manage their 
medication regimens may be linked to maintaining positive health outcomes.   
     An additional suggestion for the direction of future research would be to address the 
social validity of self-management skills for adolescents who have been prescribed 
psychotropic medications for a psychiatric diagnosis. Social validity was originally 
defined as a qualitative measure that could be used to determine the: a) significance of 
goals chosen; b) acceptability of procedures used; and, c) importance of outcomes that 
were the result of an intervention (Wolf, 1978). Positive results of social validity 
measures are hypothesized to be directly related to the likelihood that people will be 
willing to start, complete and maintain interventions. Wysocki et al. (1997) found that 
higher social validity scores were correlated with  better treatment outcomes for children 
and parents in a diabetes education intervention, although this finding has not been 
replicated. While the hypothesis that higher social validity scores are related to 
maintained use of a medical procedure seems reasonable and may have considerable 
support in the clinical experience of practitioners, there is little empirical evidence to 
support it as yet.  
 51
     Despite the current limitations of the study, some conclusions seem to be reasonably 
justified on the basis of the current data. Adolescents can be taught the skills needed to 
provide important information about their medications to their health care provider (in 
this case advanced practice nurse). Teaching adolescents how to present information 
about their health routines and their responses to medications to the health care provider 
increases the opportunity for the health care provider to respond to the stated preferences 
of adolescents. Health care providers can reinforce the role of information provider and 
can respond positively to preference statements by adolescents in ways that seem to 
benefit both the adolescent and the health care provider.  Hopefully, once adolescents 
learn effective health self-management skills, they will continue to use those skills well 
into adulthood.  
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Curriculum 
 
Week one: General Overview 
 
1. Sign-in 
 
2. Go over class outline- table of contents. 
 
3. Pre-test. 
 
4. Goal of this class. 
 
The goal of this class is to inform and teach each of you about your diagnosis, post 
traumatic stress disorder.  I want each of you to leave this course knowing what post 
traumatic stress disorder is, signs and symptoms, treatments (medications & therapy).  I 
will also be bringing in some guest speakers to talk to you about various aspects of the 
behavioral responses. One person will be a pharmacist to answer your questions about the 
medications you are taking and the other will be an adult with a history of abuse.  There 
will be time to talk about your responses and I will answer questions if I can.  If I don’t 
know the answer at that time, then by the next class I will have the answer for you (if 
possible).  Overall, the goal is for you to have a better understanding of what post 
traumatic stress disorder is and how this affects you as an individual. 
 5. What is post traumatic stress disorder? 
Post traumatic stress disorder can occur following an event that happens to you or that 
you witness happening to someone around you. The event is life- threatening and you or 
the person you see is very frightened. If you do not get help about this event then it can 
continue to cause problematic responses for a long time. Post traumatic stress disorder 
has been around since ancient times. During the Civil War there were documented cases 
but it had a different name. There was more written about it after World One and the 
Holocaust. Then after the Viet Nam War the government began studying post traumatic 
stress disorder very closely. Thirty percent of the veterans that returned from that war 
suffered from post traumatic stress disorder. We know that children and adolescents can 
experience post traumatic stress disorder after a catastrophic event.      
 
6. What Are Some Possible Causes of post traumatic stress disorder? 
 
Youth may be diagnosed with post traumatic stress disorder if they have experienced at 
least one traumatic event in their life. Those events can include disasters such as floods, 
violent crimes such as kidnapping, rape or murder of a parent, sniper fire, school 
shootings, motor vehicle accidents, plane crashes, severe burns, sexual and physical 
abuse and war.  
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7. How many children and adolescents develop post traumatic stress disorder? 
 
Rates of post traumatic stress disorder are much higher in children who have experienced 
at least one traumatic event. Studies indicate that 15 to 43% of girls and 14 to 43% of 
boys have experienced at least one traumatic event in their lifetime. Of those children 3 to 
15% of girls and 1 to 6% of boys will be diagnosed with post traumatic stress disorder. 
100% of children who witnessed a parent being killed developed post traumatic stress 
disorder. Ninety percent of those youth who were sexually assaulted developed post 
traumatic stress disorder. Seventy-seven percent who witnessed a school shooting and 
thirty-five percent who were exposed to community violence developed post traumatic 
stress disorder.  
 
 
8. What are some facts and myths? 
Facts: 
 Anyone can be diagnosed with post traumatic stress disorder.  Race, 
sex, age play no part in the selection. 
 Post traumatic stress disorder can be treated at this time. 
 Post traumatic stress disorder effects adolescents who have been 
exposed to a violent or frightening event. 
Myths. 
 You are crazy, a bad person, a psycho or nuts.  Incorrect, you have a 
behavior that can be modified. 
 You choose to be upset. Nobody who has post traumatic stress 
disorder chooses to be traumatized.  
 You can’t lead a “normal life”.  Incorrect, many people diagnosed with 
post traumatic stress disorder are active, functioning people. There are 
interventions which can reduce your fear behaviors. Those problem 
behaviors can be modified.  
 It’s contagious – FALSE 
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9.  What are the symptoms of post traumatic stress disorder in children?  
Responses to post traumatic stress disorder in adolescents are more like adult 
responses than the responses of children. Their responses involve the spontaneous 
recovery of an event that scared you. Adolescents may act as if they are in danger as a 
result. They may be impulsive or aggressive. Fear is a normal response to dangerous 
situations. But with post traumatic stress disorder the fear lasts long after the situation 
has passed. Triggers or cues may cause the fear. Some of those triggers can include 
places, times of the day, certain smells or noises or any situation that reminds you of 
the event. If you can pay more attention to the times that you act afraid then you may 
be able to modify your behavior. (Introduce the Symptom Chart). People may re-
experience the event in the form of flashbacks. Nightmares are common. A person 
may feel jumpy, jittery or easily startled or may have trouble sleeping or 
concentrating.   Avoidance is another way of dealing with the event. The person may 
want to avoid situations that remind them of the event and if that doesn’t work the 
person may have trouble remembering the event altogether. The person may be angry 
or irritable. They may blame themselves for the attack or others might try to blame 
them. This is never true but people may begin to think it is. The person may not want 
to spend time with other people or may show fear behavior when alone. Other 
problems that youth may have that relate to post traumatic stress disorder are changes 
in sleep patterns, changes in eating patterns and substance abuse.   
Symptoms may include:  
 fear behavior 
 spontaneous recovery of the event 
 flashbacks 
 nightmares 
 increased arousal 
 irritability 
 avoidance of the situation where the trauma happened 
 flat affect or numbness 
 anger 
 guilt  
 shame 
 helplessness  
 depression 
 grief 
 fear of people  
 increase in use of alcohol or other drugs 
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Loss of trust:  I felt like I could never trust anyone ever again. At first I couldn’t 
think about having sex and then I began to numb myself like I wasn’t even there 
when I was having sex. 
 
Flashbacks:  I couldn’t stand the smell of burning rubber because it reminded me of 
the smell of the accident. I would start to re-live the accident again just like it was still 
happening. 
 
 
9.  Symptom tracking sheet – handout. Participants will be instructed on how to fill 
the document out and are asked to begin that night and fill in for the next 24 days. 
 
10. Personal Medication Survey filled out by each participant 
 
11. Post-test. 
 
12. Consent administered 
 
13. The assignment for the fifth class will be discussed. Participants will be 
expected to think of and ask the pharmacist two questions about their medication and 
their symptoms and two questions about their side effects of their medicine during the 
question/answer part of the class.  
 
 
Week Two– Diagnosis and Treatment 
     1. Sign-in 
2. Knowledge Pre-test 
3. How is post traumatic stress disorder diagnosed? 
 
There are six major criteria for diagnosing post traumatic stress disorder:       
 The first criterion is the presence of a catastrophic event.  
 The second criterion is fear about the event which may remain for a 
lifetime and can evoke nightmares, flashbacks or trouble focusing during 
the day. 
 The third criterion is avoidant or numbing symptoms such as avoiding any 
trauma related stimuli (includes dissociation and a form of amnesia).  
 The fourth criterion is hyper-vigilance or startle reflex 
 The fifth criterion is that the symptoms must last at least a month and may 
last a lifetime if untreated. 
 The final criterion is that the distress experienced was significant.   
These six criteria are described in the Diagnostic and Statistical Manual for Mental 
Disorders, fourth edition (DSM-IV).  
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4. Different types of treatment 
A good treatment plan includes medication, close monitoring of symptoms, education 
about the illness, behavioral therapy for the individual, support for the family, 
relaxation techniques such as biofeedback instruction, good nutrition, regular sleep 
and exercise, and participation in a network of support.  
 Medication may be one tool used to help 
 Behavioral therapy helps to change the fear response.  
 Treatment facilities and hospitalizations – Crittenton is an example of 
residential treatment. There is also short term hospitalization for short 
term high risk patients. 
 
5.  Medications 
Medications for post traumatic stress disorder are prescribed by psychiatrists—
medical doctors (osteopaths or allopaths) with expertise in the diagnosis and 
treatment of mental disorders. While primary care physicians who do not specialize in 
psychiatry also may prescribe these medications, it is recommended that people with 
post traumatic stress disorder see a psychiatrist for medication and check with their 
pharmacist whenever medications are prescribed. 
 Medications known as selective serotonin reuptake inhibitors (SSRI) 
usually are prescribed to help treat symptoms of post traumatic stress 
disorder. Two different medications have recently been approved for 
the treatment of post traumatic stress disorder. They are Paxil 
(Paroxetine) and Zoloft (Sertraline)  
 Changes to the treatment plan may be needed at various times during 
the course of post traumatic stress disorder to manage the diagnosis 
most effectively. Symptoms are different for every person so a variety 
of medications may be used. A psychiatrist will change types or doses 
of medication.  
 Be sure to tell the psychiatrist about all other prescription drugs, over-
the-counter medications, or natural supplements you may be taking. 
This is important because certain medications and supplements taken 
together may cause adverse reactions.  
 To reduce the chance of symptoms returning it is important to stick to 
the treatment plan. Talk to your doctor and your pharmacist if you 
have any concerns about the medications.  
6.  Treatments 
As an addition to medication, behavioral therapy can be very effective in reducing the 
fear behavior associated with post traumatic stress disorder. Support, education, and 
guidance can also be helpful to people with post traumatic stress disorder and their 
families. Studies have shown that behavioral interventions can lead to better health 
outcomes. A licensed Applied Behavior Analyst, psychologist, social worker, or 
counselor typically provides these therapies and often works together with the 
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psychiatrist to monitor a patient's progress. The number, frequency, and type of 
sessions should be based on the treatment needs of each person. 
Behavioral therapies used for post traumatic stress disorder usually target the fear 
responses that are typical of post traumatic stress disorder and desensitize the patient 
to the stimuli that create the fear response. Behavioral therapy, education, medication 
and family therapy all help to increase the positive behaviors associated with 
improvement. Psycho education involves teaching people with post traumatic stress 
disorder about the diagnosis and its treatment, and how to recognize symptoms so that 
early intervention can be sought before long term problems occur. Psycho education 
also may be helpful for family members.  
 Family therapy uses strategies to reduce the level of distress within the 
family.   
 The treatment plan should be individualized because each patient’s 
response to their traumatic event will be different. Many factors 
contribute to the severity of the fear response and often talk therapies 
will concentrate on those factors. Behavioral interventions will focus 
on the fear behaviors that occur in response to the negative stimuli 
associated with the traumatic event. Ex. Smells may trigger 
spontaneous recovery of the fear response. It is important to remember 
that the collaboration between patient and treatment provider should 
create a treatment plan that is individualized for each patient. One way 
of determining the stimuli for problem behaviors may be by 
performing a functional assessment.  
      7.  Treatment Facilities and Hospitalization 
Residential 
Residential treatment programs are designed for adolescents who need a structured, 
safe, and secure environment. The program helps adolescents develop new problem 
solving skills such as anger management, problem resolution, and coping skills. They 
also can increase social skills. Residential patients may have long-standing problems 
that often have resisted management in other programs or the resident may lack the 
support system needed for treatment. Adolescents in this program participate in 
school sessions, individual, group, and therapeutic recreational activities. 
Psychiatrists manage medication for psychiatric disorders. 
Hospital 
Each patient is under the care of a psychiatrist, who works with a multidisciplinary 
team of behavioral health professionals. It is usually used for short-term crisis 
intervention. If a person is suicidal or doing other risky behaviors, a hospital stay may 
be used to keep the patient safe, adjust medications if needed, provide therapy, and 
help the patient get through the crisis period. The team helps youth understand their 
behavior and learn how to manage it.  
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Help can also be found with: 
 Behavioral psychologists 
 School programs – school nurse 
 Hospital departments of psychiatry  
 Private psychiatric offices and clinics  
 Offices of family physicians, internists, and pediatricians  
 Public community mental health centers  
People with post traumatic stress disorder may need help: 
 People with post traumatic stress disorder may not link their problems 
to their fear responses.   
 A person with post traumatic stress disorder may need much positive 
reinforcement from family and friends to seek treatment. Family 
physicians can play an important role in providing referral to a mental 
health professional.  
 Sometimes a family member or friend may need to take the person 
with post traumatic stress disorder for a mental health evaluation and 
treatment.  
 A person who is in the midst of a reaction may need to be hospitalized 
for his or her own safety and for much-needed treatment. There may 
be times when the person will be hospitalized against his or her wishes 
if that person does things to hurt themselves or others.    
8.  Knowledge Post-test. 
Week Three – Video and Discussion  
1. Sign-in 
2.  Watch video “Teens and Trauma”  
3.  Discuss video. 
4. Discuss Symptom Tracking sheet: ask if anyone has found out anything from  
    tracking their symptoms. 
5.  Participant evaluation measure given to each participant.   
Week Four – Video and Discussion  
 
1. Sign-in 
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2.  Watch video “Abused Boys, Wounded Men” (Before viewing please warn 
participants that some of the people in the video may make them uncomfortable or may 
talk about upsetting things. Instruct them that if this happens they may ask to speak 
privately with the therapist who is there during the session) 
 
3.  Discuss video. Remind participants to bring in questions for the pharmacist. 
 
4.  Participant evaluation measure given to each participant.   
Week Five– Guest Speaker (Pharmacist) on Medication 
1. Sign-in 
2. Pre-test. 
3. Pharmacist will lecture on medications used to treat post traumatic stress disorder. 
The pharmacist will discuss medications commonly used to treat post traumatic stress 
disorder, what happens if you combine those medications with other medications or over-
the counter-drugs and with natural supplements. The pharmacist will also talk about 
combining medications, side effects of medications and compliance issues.  
4. The pharmacist will take questions during and after the presentation (each 
participant must ask two questions about their medications and two questions about the 
side effects to get all eight points for this class). 
5. Post-test.  
Week Six – Living with Post Traumatic Stress Disorder 
1. Sign-in 
2.  Guest speaker (adult) will give history of abuse and describe symptoms 
experienced. After speaking the participants can ask questions and make statements on 
the topic for this group. 
3.  Participant evaluation measure given to each participant.   
Week Seven – Self-injurious behavior and substance abuse 
1. Sign-in 
2.  Pre Knowledge Test. 
 
3.  Self-injurious behavior.  
Some people with post traumatic stress disorder may try to hurt themselves. Anyone who 
is thinking about committing suicide needs immediate attention, preferably from a mental 
health professional or a physician. Anyone who talks about suicide should be taken 
seriously. Signs that may accompany self-injurious behavior may include: 
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 talking about wanting to die  
 verbalizations about nothing ever changing, nothing one does makes 
any difference or being a burden to family and friends  
 abusing alcohol or drugs  
 putting affairs in order (e.g., organizing finances or giving away 
possessions to prepare for one's death)  
 writing a suicide note  
 putting oneself in harm's way, or in situations where there is a danger 
of being killed  
While some suicide attempts are carefully planned over time, others are acts with no 
plan. It is important to understand that suicidal behavior can be changed with help. 
      4. Are substance abuse and addiction related to post traumatic stress disorder ?  
Teens with untreated post traumatic stress disorder may use alcohol and drugs. Any child 
or adolescent who abuses substances should be evaluated.  Adolescents who had a normal 
routine and seemed normal until a traumatic event and then experience a comparatively 
sudden onset of new behaviors should be observed. Increased use of drugs or alcohol 
could happen. If addiction develops, it is essential to treat both the post traumatic stress 
disorder and the substance abuse at the same time.  
5. Rehearsal of behaviors listed by Personal Medication Survey that will earn points 
for participant during treatment reviews 
 
6.  Post-test. 
 
Week Eight – Discussion and Review 
 
1. Sign-in 
 
2.  Discussion and participant questions about post traumatic stress disorder 
curriculum.  
 
3.  Review and complete Personal Medication Survey (explain reward system for 
treatment reviews again). 
 
4.  Round Robin question and answer review: participants sit in a circle and each 
participant is asked a question based on the curriculum until each participant has 
answered four questions correctly. 
 
5.  Class Evaluation given to each participant to rate procedures and importance of the 
course.  
 
6.  Party. 
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Personal Medication Survey 
Date_______________________ 
First Name and Last Initial___________________________________ 
What is the information that you have learned about your symptoms from your symptom  
tracking sheet? ____________________________________________________________________________ 
____________________________________________________________________________ 
____________________________________________________________________________ 
 
Medication # 1 Medication # 2 Medication # 3 
Name: Name: Name: 
Symptoms you take it for:  
 
 
Symptoms you take it for: Symptoms you take it for:  
How bad is this symptom: 
 
5           4        3          2          1 
Really  Bad  Not      Have Don’t 
Bad            Good or  But   Have           
                    Bad      Don’t Any 
                                Bother  
                                Me 
How bad is this symptom: 
 
5           4        3          2          1 
Really  Bad  Not      Have Don’t 
Bad            Good or  But   Have            
                    Bad      Don’t Any 
                                Bother  
                                Me 
How bad is this symptom: 
 
5           4        3          2          1 
Really  Bad  Not      Have Don’t 
Bad            Good or  But   Have     
                    Bad       Don’t Any 
                                 Bother  
                                 Me 
The medication makes this 
symptom: 
5            4         3          2         1 
Whole Worse  No        A         A 
Lot                  Worse  Little   Lot 
Worse                          Better Better   
The medication makes this symptom: 
5            4         3          2         1 
Whole Worse  No       A         A 
Lot                  Worse  Little   Lot 
Worse                          Better Better   
The medication makes this 
symptom: 
5            4         3         2          1 
Whole Worse  No       A         A 
Lot                  Worse Little    Lot 
Worse                      Better Better   
                                 
The bad side effects of this 
medication for me are: 
 
 
 
 
The bad side effects of this 
medication for me are: 
 
The bad side effects of this  
medication for me are: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 69
 
 
 
 
 
 
 
The bad side effects are: 
 
5            4       3         2          1 
Really  Bad   Not     Have  Don’t       
Bad               Good   Them Have             
                    Or Bad  But     Any 
                                  Don’t 
                                 Bother 
                                  Me     
 
The bad side effects are: 
 
5            4       3         2         1 
Really  Bad   Not     Have  Don’t       
Bad               Good   Them Have             
                    Or Bad  But     Any 
                                 Don’t 
                                 Bother 
                                 Me     
 
The bad side effects are: 
 
    5        4       3         2         1 
Really  Bad  Not     Have  Don’t       
Bad             Good   Them  Have             
                   Or Bad  But     Any 
                                Don’t 
                                Bother 
                                Me     
 
The good effects of this medication are: 
 
 
 
 
 
The good effects of this medication are: 
 
The good effects of this medication are: 
 
The good effects of this medication are: 
       5          4         3        2          1 
Fantastic Really Good SlightlyNot 
                                               Good           
                                               Or 
                                               Bad 
The good effects of this medication are: 
       5             4      3         2         1 
Fantastic Really Good Slightly Not   
               Good             Good    Good 
                                                  Or 
                                                  Bad         
The good effects of this medication are: 
5              4            3          2            1  
Fantastic Really  Good  Slightly   Not   
                Good              Good      Good 
                                                      Or 
                                                      Bad      
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Consent and Assent 
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Participant Assent Form 
 
 
Assent of Minor to participate in a Study: Does the medication compliance group 
help you do better after you get out of Crittenton? 
 
 
You are being asked to take part in a group called PTSD/Post Traumatic Stress Disorder 
at Crittenton Children’s Center (CCC). This group will help you learn about the 
symptoms of Post Traumatic Stress Disorder and how you get it. When you first talk 
about joining this group with your guardian and then with the researcher you will be 
asked to fill out this assent form.     You do not have to take part in this group. You may 
stop taking part at any time by telling Jan Talley or by calling her at 816-767-4242. If you 
choose to not take part in the group, you will not get in any trouble, and you will continue 
to receive care at CCC. 
 
This group may help you better understand your symptoms and medication for Post 
Traumatic Stress Disorder.  These are some of the things that you will do in group: watch 
movies about Post Traumatic Stress Disorder, listen to speakers, fill out forms about 
medication, discuss topics about Post Traumatic Stress Disorder and have healthy snacks 
at the end of group.  Some questions during group might be uncomfortable and you do 
not have to answer these. You will write answers to questions before and after each Post 
Traumatic Stress Disorder group about things you learned that day in group.   If you 
choose to attend this group and participate, you will be given eight points at the end of 
each week. 
 
There will be eight groups that last about one hour and fifteen minutes each and will be 
on eight week nights. There are two homework assignments. The first one is to fill out a 
medication list and the second one is to fill out a symptom tracking sheet. These two 
assignments will be for you to keep. The two homework assignments will be your 
property and will be kept by you on your person. All other data which include:  1)  your 
pre and post tests,  2) your opinion measures about the course, 3) the behavior rating 
scale. 4)  the number of questions that you ask the pharmacist,  as well as 5) any incidents 
of medication non-compliance, will be stored in a locked cabinet in a locked office. The 
study investigator and study manager will be the only persons having access to the locked 
cabinet. Questions about medication, daily routines, diagnoses and symptoms will be 
discussed. The number of questions that you ask the pharmacist about your medications 
and your side effects will be recorded but not what your questions are about. 
 
Confidentiality 
The researchers will keep your records related to the study private unless disclosure  
1) is required  by law (including court orders, court ordered warrants, subpoenas),  
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2) is needed to identify or locate a person who is a suspect, fugitive, material witness 
or missing person,  
3) is needed to get information about a victim or suspected victim of a crime,  
4) is needed to alert law enforcement of a person’s death if related to criminal 
activity,  
5) is needed if health information is evidence of a crime that occurred on its premises,  
6) is needed in a medical emergency not occurring at CCC but necessary to police a 
crime, the location of the crime or crime victims and who did the crime.   
 
By signing this form, you give permission for your information from the study to be 
reviewed by the Saint Luke’s Institutional Review Board to protect you. If Crittenton 
Children’s Center decides to publish study data, they will not identify you. If you want to 
take back your permission to release your health records, you may do so by writing to Jan 
Talley at Crittenton Children’s Center at 10918 Elm Street, Kansas City, Missouri, 
64134. You may also call Jan Talley at 816-767-4242 and ask to be withdrawn from the 
study. This will be done immediately, and your study data will be shredded in a secure 
and confidential manner.  
 
If you choose to enroll in this study, you can do so by signing this assent form. Your 
name will be entered into a log and will be assigned a number. All records of your pre 
and post tests and the opinion measures, the behavior rating scale score and the number 
of questions you ask of the pharmacist, as well as any incidents of medication non-
compliance, will be identified by that number once it is entered into the study records. 
The list containing your name will be kept in a locked cabinet in a separate locked room, 
and the key to that cabinet will only be used by the study investigator and study manager. 
The data will be stored in a locked cabinet in a locked room separate from the log book 
with subject names. The data will be stored in a secure and confidential place for seven 
years. This assent is good for one year after date you sign it, but the data may be used for 
seven years and will be stored for seven years in a confidential place as long as neither 
your assent nor the consent of your parent or guardian is  revoked.   
 
 
If you agree to be in the group sign your name below.  
 
 
 
 
 
________________________________________          ________________________   
Signature of patient             Date 
 
 
 
 
 
 
In my opinion, the nature of the study and its risks and benefits have been adequately 
explained to the minor subject, and he/she has voluntarily agreed to participate. 
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_______________________________________        ___________________________  
Signature of child advocate        Date    
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Knowledge Tests 
 
 
 
 
 
NAME_________________________________________ 
 
DATE__________________________________________ 
 
BIRTH DATE____________________________________ 
 
 
Pre-Test Class # 2 
 
 
1. How is Post Traumatic Stress Disorder diagnosed? 
 
________________________________________________________________ 
 
________________________________________________________________ 
 
 
2. Name three different types of treatment for PTSD. 
 
a)________________________________________ 
 
b)________________________________________ 
 
c)________________________________________ 
 
 
 
3. Name two medications used to treat PTSD. 
 
a)________________________________________ 
 
b)________________________________________ 
 
 
4. People who have PTSD can get control of their symptoms and live a good life. 
 
  True   False 
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DATE_____________________________________ 
 
FIRST NAME, LAST INITIAL________________ 
 
DATE OF BIRTH___________________________ 
 
MEDICATION CLASS # 5 PRE-TEST 
 
 
1. Name one medication that you are taking for Post Traumatic Stress Disorder:  
 
____________________________________________________________________ 
 
 
2. Name the symptom that medication is used to treat.  
 
____________________________________________________________________ 
 
 
3. Medications can interact with each other. Circle the correct answer. 
 
 
                       True                    False 
 
 
4.Name one side effect that you can have from your medication. 
 
   ______________________________________________________ 
 
 
5. Medication can take weeks to become effective. During that time you should continue 
to take your medication. Circle the correct answer. 
 
 
True  False 
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DATE_______________________________________________________ 
 
FIRST NAME, LAST 
INITIAL_____________________________________________________ 
 
DATE OF 
BIRTH______________________________________________________ 
 
MEDICATION CLASS # 7 PRE-TEST 
 
1. Do some people with post traumatic stress disorder want to commit suicide? Please 
explain what they should do.  
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
 
2. How is addiction related to post traumatic stress disorder?  
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
 
3. Could substance abuse be a response to a traumatic event? Please explain. 
 
________________________________________________________________________ 
 
________________________________________________________________________  
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DAILY SYMPTOM CHART 
 
Name:__________________________________________ 
Day:   __________________________________________ 
Date:  __________________________________________ 
Symptoms Scale 
My symptoms                 
Were:          1    2   3   4   5   6   7    8  9  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   
Unbearable                          
Very Bad                          
Bad                          
A Little 
Bad 
                         
Almost 
None 
                         
None                          
Appetite 
               1   2   3  4   5   6   7   8  9  10 11  12 13 14 15 16 17 18 19 20 21 22 23 24  
Eating 
Too Much 
                        
Eating 
Normal 
                        
Not 
Eating 
Enough 
                        
Sleep Pattern 
               1   2   3  4   5   6   7   8  9  10 11  12 13 14 15 16 17 18 19 20 21 22 23 24  
What hour 
did you go 
to sleep 
                        
What hour 
did you 
wake up 
                        
Nightmare 
or Bad 
Dreams  
                        
 
Bedwetting                         
Slept 
during 
daytime 
hours 
                        
Startle 
Response 
While 
Awake 
                        
Flashbacks                         
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Medication Side Effects 
                      1   2   3  4   5   6   7   8  9  10 11  12 13 14 15 16 17 18 19 20 21 22 23 24  
Headache                         
Nausea                         
Thirsty                         
Diarrhea                         
Drowsiness                         
Hand 
Tremors 
                        
 
Work 
                      1   2   3  4   5   6   7   8  9  10 11  12 13 14 15 16 17 18 19 20 21 22 23 24  
Went Well                         
Went 
Badly 
                        
Worked 
These 
Hours 
                        
 
School 
                      1   2   3  4   5   6   7   8  9  10 11  12 13 14 15 16 17 18 19 20 21 22 23 24  
Went Well                         
Went Badly                         
Attended 
TheseHours 
                        
 
